Search research articles
Contact Us
Filters
Showing results (21-30 of 80) with videos related to
Page
of 8
Sort By:
Clinical Lung Cancer
|
July 13, 2024
MDT-BRIDGE: Neoadjuvant Durvalumab Plus Chemotherapy Followed by Either Surgery and Adjuvant Durvalumab or Chemoradiotherapy and Consolidation Durvalumab in Resectable or Borderline-resectable Stage IIB-IIIB NSCLC
Martin Reck, Ernest Nadal, Nicolas Girard, et al.
Frontiers in Oncology
|
May 12, 2020
Effects of Surgery on Survival of Early-Stage Patients With SCLC: Propensity Score Analysis and Nomogram Construction in SEER Database
Yuyan Wang, Qiwen Zheng, Bo Jia, et al.
The Oncologist
|
July 2, 2020
A Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma
Carl M Gay, Yanhong Zhou, J Jack Lee, et al.
Cell Discovery
|
September 4, 2024
Single-cell and spatial proteo-transcriptomic profiling reveals immune infiltration heterogeneity associated with neuroendocrine features in small cell lung cancer
Ying Jin, Yuefeng Wu, Alexandre Reuben, et al.
Cell Discovery
|
December 20, 2024
Author Correction: Single-cell and spatial proteo-transcriptomic profiling reveals immune infiltration heterogeneity associated with neuroendocrine features in small cell lung cancer
Ying Jin, Yuefeng Wu, Alexandre Reuben, et al.
JTO Clinical and Research Reports
|
January 26, 2026
First Report of Response to Tarlatamab in a Patient With Histologic-Transformed SCLC From <i>ALK</i>-Rearranged NSCLC: Case Report
Kaiwen Wang, Ceylan Altintas Taslic, Patricia de Groot, et al.
CA: a Cancer Journal for Clinicians
|
June 17, 2023
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions
Zsolt Megyesfalvi, Carl M Gay, Helmut Popper, et al.
Cancer & Metabolism
|
September 24, 2021
Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer
Kasey R Cargill, C Allison Stewart, Elizabeth M Park, et al.
Signal Transduction and Targeted Therapy
|
October 4, 2022
Single-cell transcriptomic profiling reveals the tumor heterogeneity of small-cell lung cancer
Yanhua Tian, Qingqing Li, Zhenlin Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 8, 2023
Targeting BCL2 Overcomes Resistance and Augments Response to Aurora Kinase B Inhibition by AZD2811 in Small Cell Lung Cancer
Kavya Ramkumar, Azusa Tanimoto, Carminia M Della Corte, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 80) with videos related to
Sort By:
Page
of 8
Clinical Lung Cancer
|
July 13, 2024
MDT-BRIDGE: Neoadjuvant Durvalumab Plus Chemotherapy Followed by Either Surgery and Adjuvant Durvalumab or Chemoradiotherapy and Consolidation Durvalumab in Resectable or Borderline-resectable Stage IIB-IIIB NSCLC
Martin Reck, Ernest Nadal, Nicolas Girard, et al.
Frontiers in Oncology
|
May 12, 2020
Effects of Surgery on Survival of Early-Stage Patients With SCLC: Propensity Score Analysis and Nomogram Construction in SEER Database
Yuyan Wang, Qiwen Zheng, Bo Jia, et al.
The Oncologist
|
July 2, 2020
A Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma
Carl M Gay, Yanhong Zhou, J Jack Lee, et al.
Cell Discovery
|
September 4, 2024
Single-cell and spatial proteo-transcriptomic profiling reveals immune infiltration heterogeneity associated with neuroendocrine features in small cell lung cancer
Ying Jin, Yuefeng Wu, Alexandre Reuben, et al.
Cell Discovery
|
December 20, 2024
Author Correction: Single-cell and spatial proteo-transcriptomic profiling reveals immune infiltration heterogeneity associated with neuroendocrine features in small cell lung cancer
Ying Jin, Yuefeng Wu, Alexandre Reuben, et al.
JTO Clinical and Research Reports
|
January 26, 2026
First Report of Response to Tarlatamab in a Patient With Histologic-Transformed SCLC From <i>ALK</i>-Rearranged NSCLC: Case Report
Kaiwen Wang, Ceylan Altintas Taslic, Patricia de Groot, et al.
CA: a Cancer Journal for Clinicians
|
June 17, 2023
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions
Zsolt Megyesfalvi, Carl M Gay, Helmut Popper, et al.
Cancer & Metabolism
|
September 24, 2021
Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer
Kasey R Cargill, C Allison Stewart, Elizabeth M Park, et al.
Signal Transduction and Targeted Therapy
|
October 4, 2022
Single-cell transcriptomic profiling reveals the tumor heterogeneity of small-cell lung cancer
Yanhua Tian, Qingqing Li, Zhenlin Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 8, 2023
Targeting BCL2 Overcomes Resistance and Augments Response to Aurora Kinase B Inhibition by AZD2811 in Small Cell Lung Cancer
Kavya Ramkumar, Azusa Tanimoto, Carminia M Della Corte, et al.
Page
of 8